We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current NSB market cap is 7.66M. The company's latest EPS is AUD -0.0074 and P/E is -6.76.
Year End 30 June 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
Total Revenue | 34k | 41k | 1.02M | 0 | 4.95M |
Operating Income | -1.74M | -2.9M | -3.21M | -10.5M | -1.17M |
Net Income | -1.66M | -2.87M | -3.18M | -10.44M | -1.07M |
Year End 30 June 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
Total Assets | 5.12M | 3.74M | 14.83M | 7.74M | 5.29M |
Total Liabilities | 62k | 89k | 223k | 2.22M | 597k |
Total Equity | 5.06M | 3.65M | 14.6M | 5.52M | 4.69M |
Year End 30 June 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
Operating | -1.41M | -2.28M | -2.6M | -6.94M | -2.3M |
Investing | -19k | -2k | -30k | -4k | N/A |
Financing | 5.93M | 961k | 13.51M | N/A | N/A |
Market Cap | 7.66M |
Price to Earnings Ratio | -6.76 |
Price to Sales Ratio | 1.46 |
Price to Cash Ratio | 1.47 |
Price to Book Ratio | 1.54 |
Dividend Yield | - |
Shares Outstanding | 144.6M |
Average Volume (1 week) | 308.59k |
Average Volume (1 Month) | 1.09M |
52 Week Change | -27.40% |
52 Week High | 0.14 |
52 Week Low | 0.035 |
Spread (Intraday) | 0 (3.7%) |
Company Name | Neuroscientific Biopharmaceuticals Ltd |
Address |
suite 5 perth, western australia 6011 |
Website | https://www.neuroscientific.com |
Industry | drugs and proprietary-whsl (5122) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions